GILD vs. ABBV
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or ABBV.
Correlation
The correlation between GILD and ABBV is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GILD vs. ABBV - Performance Comparison
Key characteristics
GILD:
0.91
ABBV:
0.84
GILD:
1.38
ABBV:
1.16
GILD:
1.20
ABBV:
1.19
GILD:
0.76
ABBV:
1.05
GILD:
1.55
ABBV:
2.88
GILD:
14.55%
ABBV:
6.95%
GILD:
24.71%
ABBV:
23.75%
GILD:
-70.82%
ABBV:
-45.09%
GILD:
-4.65%
ABBV:
-13.88%
Fundamentals
GILD:
$115.65B
ABBV:
$309.92B
GILD:
$0.09
ABBV:
$2.88
GILD:
1.03K
ABBV:
60.90
GILD:
0.53
ABBV:
0.42
GILD:
$28.30B
ABBV:
$55.53B
GILD:
$22.07B
ABBV:
$42.68B
GILD:
$3.92B
ABBV:
$24.24B
Returns By Period
In the year-to-date period, GILD achieves a 18.94% return, which is significantly higher than ABBV's 17.45% return. Over the past 10 years, GILD has underperformed ABBV with an annualized return of 3.79%, while ABBV has yielded a comparatively higher 15.26% annualized return.
GILD
18.94%
5.32%
33.32%
22.07%
11.19%
3.79%
ABBV
17.45%
4.66%
4.83%
19.28%
19.53%
15.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GILD vs. ABBV - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 3.33%, less than ABBV's 3.53% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.53% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% | 3.03% |
Drawdowns
GILD vs. ABBV - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.82%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for GILD and ABBV. For additional features, visit the drawdowns tool.
Volatility
GILD vs. ABBV - Volatility Comparison
The current volatility for Gilead Sciences, Inc. (GILD) is 5.61%, while AbbVie Inc. (ABBV) has a volatility of 6.74%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GILD vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities